News + Filings Transactions
|
KOLLURI KRISHNA KITTU
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/19/2016 | Achaogen Inc | AKAO | Purchase | Common Stock | 500k | $13.50 | $6.8M | See Note 1 | 12/19/2016 |
| 11/29/2016 | Tracon Pharmaceuticals, Inc. | TCON | Purchase | Common Stock | 869.6k | $5.75 | $5M | See Note 1 | 11/29/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Sale | Common Stock | 435 | $13.00 | $5.7k | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 1.8M | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 670k | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Common Stock | 623.2k | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Purchase | Common Stock | 338.5k | $13.00 | $4.4M | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Exercise (in-the-money or at-the-money) | Warrants to Purchase Common Stock | 80.7k | $0.07 | $5.6k | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series A Preferred Stock | 12.4M | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series B-1 Preferred Stock | 4.7M | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 10/31/2016 | Ra Pharmaceuticals, Inc. | RARX | Conversion | Series B-2 Preferred Stock | 4.4M | $0.00 | $0 | See Note 2 | 10/31/2016 |
| 09/21/2016 | Roka BioScience, Inc. | ROKA | Purchase | Series A Convertible Preferred Stock | 4k | $0.70 | $2.8k | See Note 3 | 09/21/2016 |
| 09/21/2016 | Roka BioScience, Inc. | ROKA | Purchase | Series A Convertible Preferred Stock | 4k | $0.70 | $2.8k | See Note 1 | 09/21/2016 |
| 09/21/2016 | Roka BioScience, Inc. | ROKA | Purchase | Warrant to Purchase Common Stock (right to buy) | 5.7M | $0.70 | $4M | See Note 1 | 09/21/2016 |
| 07/29/2016 | INTERLEUKIN GENETICS INC | ILIU | Purchase | Common Stock | 20.1M | $0.10 | $2M | See Note 1 | 07/29/2016 |
| 07/29/2016 | INTERLEUKIN GENETICS INC | ILIU | Purchase | Common Stock Warrant (right to buy) | 20.1M | $0.10 | $2M | See Note 1 | 07/29/2016 |
| 07/18/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 763.6k | $8.73 | $6.7M | See Note 2 | 07/18/2016 |
| 07/18/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 763.7k | $8.73 | $6.7M | See Note 3 | 07/18/2016 |
| 07/18/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 763.6k | $8.73 | $6.7M | See Note 4 | 07/18/2016 |
| 03/18/2016 | TESARO, Inc. | TSRO | Purchase | Common Stock | 710.4k | $0.00 | $0 | See Note 2 | 03/18/2016 |
| 03/18/2016 | TESARO, Inc. | TSRO | Purchase | Common Stock | 710.4k | $0.00 | $0 | See Note 3 | 03/18/2016 |
| 01/13/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 500k | $10.00 | $5M | See Note 2 | 01/13/2016 |
| 01/13/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 500k | $10.00 | $5M | See Note 3 | 01/13/2016 |
| 01/13/2016 | ARDELYX, INC. | ARDX | Purchase | Common Stock | 500k | $10.00 | $5M | See Note 4 | 01/13/2016 |
| 01/12/2016 | Epizyme, Inc. | EPZM | Purchase | Common Stock | 1.1M | $9.00 | $10M | See Note 2 | 01/12/2016 |
| 11/11/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Other (disposition) | Common Stock | 3.8M | $0.00 | $0 | See Note 2 | 11/11/2015 |
| 11/11/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Other (acquisition) | Common Stock | 1.2M | $0.00 | $0 | See Note 4 | 11/11/2015 |
| 11/11/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Other (disposition) | Common Stock | 1.2M | $0.00 | $0 | See Note 4 | 11/11/2015 |
| 11/11/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Other (acquisition) | Common Stock | 1.2k | $0.00 | $0 | See Note 7 | 11/11/2015 |
| 11/11/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | Other (acquisition) | Common Stock | 10.3k | $0.00 | $0 | See Note 7 | 11/11/2015 |
| 10/20/2015 | Avalo Therapeutics, Inc. | CERC | Conversion | Common Stock | 594.2k | $0.00 | $0 | See Note 2 | 10/20/2015 |
| 10/20/2015 | Avalo Therapeutics, Inc. | CERC | Conversion | Series B Convertible Preferred Stock | 16.6M | $0.00 | $0 | See Note 2 | 10/20/2015 |
| 10/06/2015 | SYNLOGIC, INC. | SYBX | Other (acquisition) | Common Stock | 257.5k | $0.00 | $0 | See Note 2 | 10/05/2015 |
| 10/06/2015 | SYNLOGIC, INC. | SYBX | Other (acquisition) | Common Stock | 31.6k | $0.00 | $0 | See Note 2 | 10/05/2015 |
| 10/06/2015 | SYNLOGIC, INC. | SYBX | Purchase | Common Stock | 857.1k | $7.00 | $6M | See Note 2 | 10/05/2015 |
|
|